Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2005
03/03/2005WO2004059278A3 Methods of screening for anti-inflammatory drugs and use thereof
03/03/2005WO2004025256A3 Viral deconstruction through capsid assembly in vitro
03/03/2005WO2004019883A3 Tick polypeptides as anticoagulants and vaccines
03/03/2005WO2004012767A8 Medicinal agent and method for curing erectile dysfunction
03/03/2005WO2004004668A3 Immune modulatory activity of human ribonucleases
03/03/2005WO2004000876A8 INFECTIOUS cDNA OF AN APPROVED VACCINE STRAIN OF MEASLES VIRUS, USE FOR IMMUNOGENIC COMPOSITIONS
03/03/2005WO2004000209A3 Administration of therapeutic viruses
03/03/2005WO2003045317A3 Therapeutic protein and treatments
03/03/2005WO2002062203A9 Compositions and methods for the therapy and diagnosis of breast cancer
03/03/2005US20050050191 Storage network and method for storage network device mapping
03/03/2005US20050049216 Immunostimulatory nucleic acid molecules
03/03/2005US20050049215 contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulating interferon-alpha to treat viral infections; oligonucleotide linked to a biodegradable delivery complex
03/03/2005US20050049212 Eating disorders, cachexia, diabetes mellitus, hypertension, coronary heart disease, hypercholesterolemia, osteoarthritis, gallstones, cancers of the reproductive organs, and sleep apnea; drug screening; diagnosis and therapy; kits; regulates metabolism of triglycerides
03/03/2005US20050049197 Induction of immune response against desired determinants
03/03/2005US20050049194 Use of ephrins and related molecules to regulate cellular proliferation
03/03/2005US20050049176 Treating a hypoproliferative cell disorder or disorder involving increased cell death in a patient by administering a therapeutically effective amount of an EphA2 antagonistic agent; treatment of Inflammatory Bowel Disease
03/03/2005US20050048646 Method for inducing cytotoxic T lymphocyte
03/03/2005US20050048645 Dendritic cells which present cryptococcus antigens for use in generating vaccines to prevent or treat microorganismal infection; immunotherapy; drug targeting and parasitic infection
03/03/2005US20050048639 Caspase-8 binding protein, its preparation and use
03/03/2005US20050048632 Novel DNA encoding Eimeria glyceroaldehyde-3-phosphate dehydrogenase and uses thereof
03/03/2005US20050048628 Immunological binding molecules inhibiting the syncytial fusion of trophoblast
03/03/2005US20050048590 Streptococcal enolase for use in generating immunoglobulins for use in prevention and treatment of microorganismal infection; immunotherapy
03/03/2005US20050048584 Method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases associated peptides and use thereof
03/03/2005US20050048576 Diagnosing/prognosing nut allergies; immunodiagnostics
03/03/2005US20050048565 Method of diagnosing or monitoring saccharometabolic error
03/03/2005US20050048557 Expression vector comprising nucleotide sequences coding microorganismsal protein for use in developing vaccine agents which prevent bacterial infection; bactericides; microbiocides
03/03/2005US20050048520 Nogo receptor homologs
03/03/2005US20050048507 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/03/2005US20050048483 Novel secreted proteins and their uses
03/03/2005US20050048478 Preparing agents which prevent and/or treat viral diseases; immunotherapy; mimetics
03/03/2005US20050048471 Albumin derivatives with therapeutic functions
03/03/2005US20050048469 Novel human parvovirus B19 receptor and uses thereof
03/03/2005US20050048467 Method and compositions relating to hpv-associated pre-cancerous and cancerous growths, including cin
03/03/2005US20050048466 Recombinant virus comprising virus proliferating essential gene (VPEG) for use in the treatment of cell proliferative disorders; cancer therapeutics
03/03/2005US20050048085 Exposure of infant mammal or bird to radiation detoxification lipopolysaccharide devived from microbial, fung al, protozoa endotoxin
03/03/2005US20050048083 Vaccine
03/03/2005US20050048082 Immunogen carrier; genetic engineering fusion protein
03/03/2005US20050048081 Immunogenic compositions comprising DAL/DAT double mutant, auxotrophic attenuated strains of listeria and their mehods of use
03/03/2005US20050048079 Induction response in cells; joining to adenosine triphosphate binding domain; therapy for Aids; anticancer agents
03/03/2005US20050048076 Mutant endotoxin for use in prevention of bacterial infections; bactericides; microbiocides
03/03/2005US20050048075 Protein isolation
03/03/2005US20050048074 Transgenic plant comprising nucleotide sequences coding hemagglutinin-neuraminidase (HN) proteins of newcastle disease viruses; for use in producing immunoprotective particles; vaccine preparation
03/03/2005US20050048073 Methods of determining west nile virus epitopes and method of using the same
03/03/2005US20050048072 Topical administering mixtuure of immune response moderator and another drug
03/03/2005US20050048071 Short peptide associated with leukemia that induces immunology response; cancer vaccine; leukemia antigen
03/03/2005US20050048070 Mixture of polypeptides from cytokeratins; anticancer agnets; vaccines
03/03/2005US20050048068 Major histocompatibility complex epitopes; immunotherapy ; induce immunology response
03/03/2005US20050048066 Identification of potential immunodominant acetylcholine receptor alpha subunit
03/03/2005US20050048064 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability
03/03/2005US20050048063 Collagen-binding molecules that selectively home to tumor vasculature and methods of using same
03/03/2005US20050048062 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell
03/03/2005US20050048061 Uses of mammalian cytokines and agonists; related reagents
03/03/2005US20050048059 Binding to epitope which contains peptide and carbohydrate on tumor; anticancer agents
03/03/2005US20050048058 Antibody against fibroblast growth factor-23
03/03/2005US20050048057 Diagnosis, therapy of cancer, cardiovascular disorders, atherosclerosis, restenosis, osteoporosis, antiinflammatory agents
03/03/2005US20050048055 Use of CD40 engagement to alter T cell receptor usage
03/03/2005US20050048053 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications
03/03/2005US20050048052 Bioassay for detecting expression of mammalian CC-chemokine receptor 2, by binding of antibody or antigen-binding fragment; human or humanized monoclonal antibody; test kits
03/03/2005US20050048050 Administering insulin-like growth factor binding protein; antitumor, anticancer agents ; genetic engineered antibody
03/03/2005US20050048049 A humanized antibody that binds to soluble A beta; may be monoclonal, polyclonal, single chain or fused to a heterologous polypeptide
03/03/2005US20050048029 Nucleotide sequence for diagnosis, prevention, therapy of cancer, inflammation, autoimmune disease and infections
03/03/2005US20050047996 Calibration of colorectal cancer; gene expression profile; administering to human an antibody which binds to protein markers
03/03/2005DE10335833A1 Transfektion von Blutzellen mit mRNA zur Immunstimulation und Gentherapie Transfection of blood cells with mRNA for immune stimulation and gene therapy
03/03/2005CA2816222A1 Influenza hemagglutinin and neuraminidase variants
03/03/2005CA2551075A1 Immunostimulatory combinations and treatments
03/03/2005CA2537263A1 Techniques and compositions for the diagnosis and treatment of cancer (muc1)
03/03/2005CA2536946A1 Estrogen receptor modulators and uses thereof
03/03/2005CA2536918A1 Serine protease inhibitors for treatment of bacterial infections
03/03/2005CA2536819A1 Immunogenic agent and pharmaceutical composition for use against homologous and heterologous pathogens including plasmodium spp
03/03/2005CA2536654A1 Anti-cancer vaccines
03/03/2005CA2536408A1 Improved antibodies having altered effector function and methods for making the same
03/03/2005CA2536359A1 Cytotoxicity mediation of cells evidencing surface expression of cd44
03/03/2005CA2536317A1 Poxvirus vector encoding prostate specific antigens for treatment of prostate cancer
03/03/2005CA2536288A1 Cancer metastasis inhibitor
03/03/2005CA2536086A1 Inhibition of dr3 in the treatment of allergic lung inflammation
03/03/2005CA2535976A1 A novel gene and protein associated with angiogenesis and endothelial apoptosis
03/03/2005CA2535859A1 Endotheliase-2 ligands
03/03/2005CA2535799A1 Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
03/03/2005CA2535583A1 Method of inducing immune tolerance
03/03/2005CA2534547A1 Synthetic gene encoding rhesus monkey carcinoembryonic antigen and uses thereof
03/03/2005CA2530821A1 Hiv immunogenic complexes
03/03/2005CA2529647A1 Influenza hemagglutinin and neuraminidase variants
03/03/2005CA2526431A1 Compositions and methods for treatment of severe acute respiratory syndrome (sars)
03/03/2005CA2519337A1 Anti-cancer virus desensitization method
03/02/2005EP1510580A2 Novel hepatitis C E1 and E2 truncated polypeptides and methods of obtaining the same
03/02/2005EP1510579A2 Use of heregulin as an epithelial cell growth factor
03/02/2005EP1510219A1 Method for identifying at least one Aminopeptidase-inhibitor
03/02/2005EP1509772A2 Diagnostics and therapeutics for diseases associated with neuromedin u2 receptor (nmu2)
03/02/2005EP1509767A1 Detection of autoantibodies to cytokeratin 18 protein in patients with bronchial asthma and chronic rhinitis, and its applications including a kit for diagnosing bronchial asthma and chronic rhinitis comprising mammalian cytokeratin 18 protein
03/02/2005EP1509614A1 Map-kinase inhibitors as regulators of tumor-associated antigen expression
03/02/2005EP1509607A1 Immunogenic sequences
03/02/2005EP1509606A1 Allergen from mugwort pollen
03/02/2005EP1509543A2 Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus
03/02/2005EP1509539A2 Novel compositions and methods for cancer
03/02/2005EP1509507A2 Mitotic kinesin inhibitors
03/02/2005EP1509253A1 Chimeric cd154
03/02/2005EP1509244A1 New method and composition for producing a cellular allogeneic vaccine
03/02/2005EP1509240A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
03/02/2005EP1509236A2 Treatment and prevention of abnormal scar formation in keloids and other cutaneous or internal wounds or lesions
03/02/2005EP1509166A2 Method for improving body weight gain and feed conversion efficiency in animals
1 ... 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 ... 1823